Insmed reported $25.72M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
DBV Technologies DBVT:US 4.51M 4.51M
Acelrx Pharmaceuticals ACRX:US $ 184K 24K
Alimera Sciences ALIM:US $ 18.78M 0.35M
Biomarin Pharmaceutical BMRN:US $ 430.15M 56.75M
Cytokinetics CYTK:US $ 6.06M 45.76M
Dynavax Technologies DVAX:US $ 136.94M 5.12M
Gilead Sciences GILD:US $ 3787M 706M
Heron Therapeutics HRTX:US $ 41.1M 5.6M
Insmed INSM:US $ 25.72M 1.37M
Mirati Therapeutics MRTX:US $ 1.81M 0.7M
Novartis NVS:US $ 8678M 395M
Ophthotech OPHT:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 4839M 1197.5M
Sarepta Therapeutics SRPT:US $ 197.2M 25.56M
Seattle Genetics SGEN:US $ 401.01M 11.75M
Ultragenyx Pharmaceutical RARE:US $ 28.37M 0.06M
Vertex Pharmaceuticals VRTX:US $ 1292.8M 156M